Navigation Links
In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Date:6/17/2008

Solutions' 2008 Survey of Health Care Consumers. Representative findings from the survey of more than 3,000 U.S. consumers found:

-- Nearly 90 percent of consumers are interested in using a self-

monitoring device at home if they developed a condition requiring

monitoring.

-- Twenty percent used an alternative approach to treatment, such as

homeopathic, naturopathic, acupuncture, chiropractic, and bio-electric

therapies; 40 percent might do so in the future.

-- Twelve percent consulted an alternative health care practitioner (for

example, an herbalist, homeopath or chiropractor); 38 percent might do

so in the future.

-- Nine percent substituted an alternative or natural therapy for a

prescription medication; 32 percent might in the future.

-- Thirty-two percent prefer to choose doctors with an orientation toward

holistic or alternative treatments.

-- Fourteen percent are aware of biologic drugs; consumers did not express

a clear preference between biologic and traditional pharmaceuticals.

-- Nearly 40 percent would consider traveling to a foreign country to have

an elective procedure performed if they could save 50 percent or more

and be assured that the quality was equal to or better than what is

available in the United States.

"Life sciences firms should seek to develop products that respond to consumers' desires for improved capabilities to self-monitor and manage their own care, and address their interest in alternative and personalized treatment options, as well as non-conventional delivery models," said Terry Hisey, vice chairman and industry leader of Deloitte LLP's life sciences practice. "Insights from our research indicate that there are unmet consumer needs that present opportunities for pharmaceutical manufacturers, biotechnology firms, and medical product, technology and device manufa
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
3. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
4. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
5. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
7. Sigma-Aldrich Expansion in Republic of China to Support SAFC Growth
8. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
9. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
10. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
11. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... JUPITER, Fla. , July 30, 2014 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... enzymes and other proteins for the bioenergy, bio-based ... the appointment of Thomas "Tom" Dubinski as Vice ... responsible for leading the financial and information technology ...
(Date:7/30/2014)... July 30, 2014  RXi Pharmaceuticals Corporation ... company focused on discovering, developing and commercializing ... using RNA-targeted technologies, today announced that their ... for the reduction of recurrence of hypertrophic ... been initiated. Logo - ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... 2014 “PharmaSphere: Emerging Biotech Investment ... Capital Funding” report provides in-depth analysis of the ... and venture capital segments of the financial industry, ... have significant impact on the future of emerging ... the report identifies regions of the world that ...
Breaking Biology Technology:Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4
... science and public policy with the needs of consumers ... any chance of reducing the effects of carbon on ... of the American Association for the Advancement of Science ... the global energy system, says Mike Davis, who leads ...
... morally acceptable? , For a significant percentage of Americans, ... of Americans, attitudes about the science of the very ... at the annual meeting of the American Association for ... Wisconsin-Madison professor of life sciences communication, presented new survey ...
... Therapies that Significantly Raises HDL "Good" Cholesterol and ... ... ABBOTT PARK, Ill., Feb. 15 Today, Abbott,received U.S. Food ... two widely prescribed cholesterol,therapies, Niaspan(R) (Abbott,s proprietary niacin extended-release) and,simvastatin. SIMCOR ...
Cached Biology Technology:Mission critical for carbon management 2Mission critical for carbon management 3Religion colors Americans' views of nanotechnology 2Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 2Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 3Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 4Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 5Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management 6
(Date:7/30/2014)... a multitude of cells types. Researchers would like to understand ... mature cells that make up the organs and other structures ... long chains of sugars that dangle from proteins on surfaces ... California, San Diego, has created synthetic molecules that can stand ... manipulated to direct the process, they report in the ...
(Date:7/29/2014)... by academics in the University of Bristol,s Nutrition and ... liquid calories into account when planning meals. , The ... Study of Ingestive Behavior Conference (SSIB 2014) in Seattle, ... that we do. , The team was led by ... of Experimental Psychology. , As part of a Biotechnology ...
(Date:7/29/2014)... 2014 Research and Markets  has announced ... (BI) Market 2014-2018" report to their offering. ... The term BI refers to applications and technologies that ... information about a company,s operations. BI help organizations to ... for example, metrics on sales, production, and internal operations. ...
Breaking Biology News(10 mins):Global SaaS-based Business Intelligence (BI) Market 2014-2018 2
... increase in the number of infections with a specific ... Salmonella serovar Typhimurium DT104, is resistant to at least ... genetic information in DNA of DT104 that might be ... information might also be involved in the increase in ...
... clinical trials, coronary artery bypass surgery performed on a beating ... safe option that leads to fewer negative side effects for ... Surgery. , “Previously, it was more common for doctors ... the heart and passing the blood through a heart-lung machine,?says ...
... key enzyme can soothe over-excited receptors in the brain, ... Alzheimer's and other neurodegenerative diseases. , Lead author Michel ... student Wei Xu and collaborators from the University of ... issue of Neuron. , The researchers injected ...
Cached Biology News:Salmonella survives better in stomach due to altered DNA 2Decoy pill saves brain cells 2
Fetal Calf Serum Replacement (Bistec) serum...
NEWBORN CALF SERUM AND PLASMA...
... Solid phase reagent ... purification; Easy & unique ... Compatible with detergents and ... & recover non-envelop viruses ...
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
Biology Products: